Pfizer seeks earlier use of Talzenna in prostate cancer with Phase 3 winnews2026-03-19T14:24:11+00:00March 19th, 2026|Endpoints News|
Electrostatic decatalysis offers a new way to suppress parasitic side reactionsnews2026-03-19T13:28:00+00:00March 19th, 2026|Chemistry World|
Washington’s Medicaid program will pay for ElliQ, an AI robot for lonelinessnews2026-03-19T13:00:43+00:00March 19th, 2026|Endpoints News|
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesitynews2026-03-19T11:51:29+00:00March 19th, 2026|Medical Device News Magazine|
Congruence starts human trials for first drug, raises $40Mnews2026-03-19T11:00:21+00:00March 19th, 2026|Endpoints News|
Lantern raises $30M from Morgan Health, Echo Health Venturesnews2026-03-19T11:00:00+00:00March 19th, 2026|Endpoints News|
